At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Thymidine Sparing Regimens on Mitochondrial Metabolism and Adipocyte Apoptosis
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Feb 12, 2007·Updated Sep 5, 2017
In Brief
An observational study for HIV Infections. Completed, enrolled 56 participants across 1 site.
Detailed Summary
The purpose of this study is to observe the effects of certain anti-HIV medications on mitochondrial activity and fat cell death. This study will enroll participants from another study, ACTG A5202, who are on treatment regimens that do not include zidovudine, stavudine, or other thymidine-containing anti-HIV medications.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedFeb 2007
Primary CompletionOct 2009
Study CompletionDec 2009
TodayJul 2026
First PostedFeb 12, 2007
Enrollment StartApr 1, 2006
Primary CompletionOct 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 19.4 years ago